Kevin’s Story: Living with Lambert-Eaton Myasthenic Syndrome
November 1, 2023
Meet Kevin, an Anovo patient living with Lambert-Eaton myasthenic syndrome. Despite the challenges he’s faced in not always being able to provide the way he could before his diagnosis or do all the things he wants to do on a daily basis, Kevin shares how a revolutionary therapy has transformed his life. Watch the video to hear Kevin talk about his journey and explain how Anovo stepped up to the plate to make sure he receives the care he deserves and in his own words “[has] not disappointed me one time.”
“Anovo has been a really good advocate for me through this whole process. I am really grateful for the team that I have. I feel that they have my back.”
Related Posts
Cycle Pharmaceuticals and Anovo Deliver Relief to Those with Homozygous Cystinuria
Cycle Pharmaceuticals was founded in 2012 with one mission in mind: delivering best-in-class drug treatments and services to the underserved…
July 29, 2024
Advancing Rare Disease Care: Insights from the World Orphan Drug Congress and AAN Annual Meeting
The World Orphan Drug Congress (WODC) and the American Academy of Neurology (AAN) Annual Meeting are where healthcare leaders, advocates,…
June 11, 2024
Pyros and Anovo Partner to Elevate Care for Infantile Spasms
Pyros Pharmaceuticals works to elevate the standard of care for children with rare disease by pioneering treatment options like VIGPODER™…
April 1, 2024
